X
XLinkedinWhatsAppTelegramTelegram
0
Read this article in:

FDA guidance on reporting and mitigating animal drug shortages during COVID-19 crisis

How sponsors can report shortages to the FDA and steps to take to avoid discontinuance or interruption of animal drugs and their components.

11 May 2020
X
XLinkedinWhatsAppTelegramTelegram
0

During the COVID-19 outbreak, the U.S. Food and Drug Administration continues to monitor the animal drug supply chain and work closely with animal drug sponsors, to ascertain as early as possible, any shortage or potential shortage that is likely to lead to a disruption in the availability of animal drugs or their components in the United States.

To help animal drug sponsors submit timely and informative notifications, FDA is publishing a guidance for immediate implementation about the importance of these notifications, how sponsors can notify FDA, and the details to provide about the discontinuance or interruption of manufacturing and other factors that may impact availability of animal drug products. The guide also provides information sponsors can provide proactively to help avoid shortages.

Although some supply disruptions and shortages cannot be predicted or prevented, FDA recognizes that early communication and detailed notifications from sponsors to the agency play a significant role in decreasing their incidence, impact, and duration.

This policy is intended to remain in effect only for the duration of the public health emergency related to COVID-19.

May 7, 2020/ FDA/ USA.
https://www.fda.gov

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among pig333.com users.
Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

You are not subscribed to this list Swine News

Swine industry news in your email

Log in and sign up on the list

Related articles